# Gyrodyne, LLC > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Gyrodyne, LLC). ## Overview Gyrodyne, LLC is a U.S. real estate company in liquidation that owns and manages a small portfolio of nonresidential properties, primarily Flowerfield and Cortlandt Manor. Its current business is to preserve, entitle, and sell those assets in a way that maximizes proceeds for shareholders before dissolving the company. ## Products & services • Ownership and management of nonresidential real estate • Tenant lease administration and occupancy management • Property enhancement and entitlement work • Sale of real estate assets in liquidation • Shareholder distributions after asset sales - **Real estate operations** (35%) — Rental and property management activities tied to the company's remaining operating properties. - **Property entitlement and enhancement** (20%) — Zoning, subdivision, and site plan work intended to increase the realizable value of land parcels. - **Asset disposition** (35%) — Strategic sale of Flowerfield, Cortlandt Manor, and other real estate assets. - **Liquidation and wind-down activities** (10%) — Administrative and legal work associated with settling liabilities and preparing for dissolution. - Ownership and management of nonresidential real estate - Tenant lease administration and occupancy management - Property enhancement and entitlement work - Sale of real estate assets in liquidation - Shareholder distributions after asset sales ## Customers Gyrodyne's direct customers are tenants and prospective property buyers rather than end consumers. Its tenant base supports interim cash flow while the company works through approvals and sales, and its buyers are typically real estate developers or users seeking entitled land or medical-oriented property. The company also has an indirect customer-like constituency in its shareholders, because the end goal is to return liquidation proceeds to them. - **Commercial tenants** (primary) — Lease space in Gyrodyne's properties to support occupancy and interim rental cash flow. - **Real estate developers** (primary) — Buy land or improved parcels, especially where subdivision and entitlements can unlock higher value. - **Medical and mixed-use occupiers** (secondary) — Potential users of Cortlandt Manor's medical-oriented zoning and limited retail component. - **Shareholders** (primary) — Receive residual cash distributions after liabilities are settled and assets are sold. - Commercial tenants paying rent while properties remain in operation - Real estate developers seeking entitled land or subdivided parcels - Medical or mixed-use users interested in Cortlandt Manor zoning - Buyers of whole-property or individual-lot real estate assets - Shareholders expecting liquidation distributions after asset sales ## Geography Gyrodyne's operations are concentrated in the United States, with its key assets in New York. The company specifically references Flowerfield and Cortlandt Manor, and its value realization depends on local zoning, subdivision, and site plan approvals from New York authorities. Geography matters because the liquidation timeline and sale price are heavily influenced by local entitlement outcomes. - Operations are concentrated in the United States - Key assets are Flowerfield and Cortlandt Manor in New York - Local zoning and subdivision approvals drive sale timing - New York regulatory processes affect realized property value - No country-level revenue disclosure was provided ## Strategy Gyrodyne's strategy is to maximize the value of its remaining real estate before liquidation by pursuing entitlements, subdivision approvals, and selective property enhancements. It is also trying to manage occupancy and lease cash flow while negotiating sales that may be either individual lots or whole parcels, depending on which path produces the best value and timing. - **Secure approvals for Flowerfield disposition** (short-term) — Subdivision and site plan approvals are required to close the pending sale and unlock value. - **Enhance Cortlandt Manor through zoning entitlements** (medium-term) — The medical-oriented zoning district can improve the property's highest-and-best-use value. - **Complete liquidation and dissolution** (medium-term) — The company intends to sell remaining assets, settle claims, and return cash to shareholders. - Pursue entitlements to raise the value of Flowerfield and Cortlandt Manor - Seek subdivision and site plan approvals to enable property sales - Maintain occupancy and lease cash flow during the wind-down - Evaluate whole-parcel versus lot-by-lot sales to maximize proceeds - Settle liabilities and then distribute residual cash to shareholders ## Risks Gyrodyne's biggest risk is execution risk around approvals and asset sales: if subdivision, site plan, or other governmental approvals are delayed or denied, the liquidation timeline and proceeds could be materially affected. The company also faces ongoing operating losses, limited cash runway, activist shareholder disputes, and valuation uncertainty because liquidation accounting depends on estimates of asset values and liabilities. - **Approval risk for Flowerfield sale** [high] — The transaction is contingent on subdivision and site plan approvals outside management's control. - **Liquidity and runway risk** [high] — The company expects continued operating losses and has limited cash absent additional asset sales. - **Activist shareholder disruption** [medium] — Proxy contests and governance disputes can consume time and money and complicate execution. - **Valuation and liability uncertainty in liquidation** [high] — Net assets in liquidation depend on estimates of real estate value and unknown liabilities. - Sale of Flowerfield depends on approvals that may take years or fail - Operating losses continue while the company waits for asset sales - Limited cash runway increases dependence on successful dispositions - Activist shareholder campaigns can distract management and raise costs - Liquidation value estimates can change with property and liability remeasurement ## Accounting Gyrodyne uses liquidation basis accounting, so the key financial statements are net assets in liquidation and changes in net assets rather than a conventional income statement and balance sheet. Reported results are highly sensitive to fair value remeasurement of real estate, estimates of liquidation costs, and provisions for known and unknown liabilities, which can materially change expected shareholder distributions. - **Liquidation basis of accounting** — Changes the presentation from earnings to estimated distributable value - **Fair value remeasurement of real estate** — Can materially increase or decrease net assets in liquidation - **Provision for liabilities and liquidation costs** — Reduces expected cash available for shareholder distributions - Liquidation basis accounting replaces normal operating financial statements - Real estate is remeasured based on estimated liquidation value - Known and unknown liabilities can materially reduce distributable value - Future distributions depend on estimates of sale proceeds and costs - Legal and professional fees are part of liquidation cost estimates --- *Last updated: 2026-04-28T20:12:47.309675+00:00*